ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 38 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,341,000 | -56.5% | 178,109 | -20.6% | 0.36% | -39.4% |
| Q4 2019 | $3,085,000 | +6.9% | 224,359 | -7.7% | 0.59% | -20.1% |
| Q3 2019 | $2,886,000 | -15.1% | 242,950 | 0.0% | 0.74% | +4.3% |
| Q2 2019 | $3,399,000 | -36.6% | 242,950 | -19.0% | 0.70% | -49.7% |
| Q1 2019 | $5,364,000 | +13.7% | 300,000 | 0.0% | 1.40% | -18.2% |
| Q4 2018 | $4,719,000 | – | 300,000 | – | 1.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 4,081,972 | $9,388,000 | 2.74% |
| RA Capital Management | 11,028,722 | $25,366,000 | 0.35% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $15,984,000 | 0.31% |
| Avidity Partners Management LP | 3,836,798 | $8,825,000 | 0.20% |
| Casdin Capital, LLC | 2,575,000 | $5,923,000 | 0.15% |
| Vivo Capital, LLC | 1,325,736 | $3,049,000 | 0.14% |
| Artal Group S.A. | 1,803,858 | $4,149,000 | 0.09% |
| Eversept Partners, LP | 569,581 | $1,310,036 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 374,811 | $862,000 | 0.09% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,315 | $2,480,000 | 0.07% |